grail.comHealthcare / BioTech & PharmaFounded: 2016Funding to Date: $2.02B
GRAIL is a healthcare company specializing in early cancer detection by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art computer science and data science to developed a multi-cancer early detection blood test.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
05/06/2020 | Series D | $392.01MM | $xx.xx | $4.26B | Canada Pension Plan Investment Board, Illumina, Public Sector Pension Investment Board | |
Price per Share
$xx.xx
Shares Outstanding
76,743,836
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Canada Pension Plan Investment Board, Illumina, Public Sector Pension Investment Board
|
||||||
05/21/2018 | Series C | $300MM | $xx.xx | $3.2B | 6 Dimensions Capital, Ally Bridge Group, Blue Pool Capital, China Merchant Securities International, Crf Investment, Hillhouse Capital Group, Huangpu River Capital, Icbc International, Sequoia Capital China, Wuxi Nextcode | |
Price per Share
$xx.xx
Shares Outstanding
63,144,600
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
6 Dimensions Capital, Ally Bridge Group, Blue Pool Capital, China Merchant Securities International, Crf Investment, Hillhouse Capital Group, Huangpu River Capital, Icbc International, Sequoia Capital China, Wuxi Nextcode
|
||||||
11/22/2017 | Series B | $1.24B | $xx.xx | $2.35B | Amazon, Arch Venture Partners, Goldman Sachs, Johnson & Johnson Innovation, Mckesson Ventures | |
Price per Share
$xx.xx
Shares Outstanding
309,256,591
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Amazon, Arch Venture Partners, Goldman Sachs, Johnson & Johnson Innovation, Mckesson Ventures
|
||||||
01/08/2016 | Series A | $85MM | $xx.xx | $212.5MM | Amino Capital, Arch Venture Partners, Bezos Expeditions | |
Price per Share
$xx.xx
Shares Outstanding
85,000,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Amino Capital, Arch Venture Partners, Bezos Expeditions
|